Stanley Cohen

10PUBLICATIONS
26CO-AUTHORS
AutoimmunitySensory systemsRheumatology and arthritisCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 11, 2025
Real-World Experience with an Adalimumab Biosimilar (ABP 501) in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis and Psoriasis in Europe: Results from the Adelphi Disease Specific Programme.

Ran Jin, James M Haughton, Emily J Goddard

|Jun 30, 2023
A Randomized, Double-Blind, Sham-Controlled, Clinical Trial of Auricular Vagus Nerve Stimulation for the Treatment of Active Rheumatoid Arthritis.

Matthew C Baker, Sarah Kavanagh, Stanley Cohen

|Feb 08, 2023
Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis.

Gerd R Burmester, Stanley B Cohen, Kevin L Winthrop

|Dec 16, 2022
Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs.

Kevin L Winthrop, Arne Yndestad, Dan Henrohn

|Feb 02, 2021
Upadacitinib in Rheumatoid Arthritis: A Benefit-Risk Assessment Across a Phase III Program.

Philip G Conaghan, Eduardo Mysler, Yoshiya Tanaka

|Apr 10, 2020
Fenebrutinib versus Placebo or Adalimumab in Rheumatoid Arthritis: A Randomized, Double-Blind, Phase II Trial (ANDES Study).

Stanley Cohen, Katie Tuckwell, Tamiko R Katsumoto

Pageof 2

Frequent Collaborators

2 joint publications

Kevin L Winthrop

2 joint publications

Yoshiya Tanaka

2 joint publications

Gerd R Burmester

1 joint publications

Theodore Mellors